Here’s what you should know.
1. Dr. Riccardi was recognized for his level of training and experience with NeoTract’s UroLift System. He uses the system to treat symptoms associated with benign prostatic hyperplasia.
2. Dr. Riccardi said of the designation, “It is rewarding to be able to offer my patients a breakthrough treatment option that offers real long-term results.”
3. The UroLift system provides BPH patients relief. According to randomized study data, patients treated with the UroLift system experienced symptom relief with minimal side effects, the press release notes.
More articles on leadership:
125k procedures in 30 years: HCA’s Surgery Center of Rome celebrates anniversary
Gateway Ambulatory Surgery Center secures $87k equity financing
Compass Surgical Partners, Martin Health open GI ASC: 4 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.